Metoprolol Succinate Tablet, Extended Release
Product Images NDC 70518-3122

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Metoprolol Succinate (NDC 70518-3122). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
Metoprolol Succinate is an extended-release medication manufactured by Zydus Pharm, Pennington, N.J 08534, and repackaged by RemedyRepack Inc., Indiana, PA 15701, with NDC #: 70518-3122-00. The LOT # and expiration date are not available. Please see the package insert for directions for use. Store the medication at 20-26°C (63-77°F), with excursions permitted to 15-30°C (59-86°F) [See USP]. This medication should be kept out of the reach of children.*
FDA Label Image

Figure (Fe222a69 B261 4e41 83ab Af76ee17812d 01)

FDA Label Image

Figure (Fe222a69 B261 4e41 83ab Af76ee17812d 02)

Figure (Fe222a69 B261 4e41 83ab Af76ee17812d 02)
Results for Subgroups in MERITHE are available including data such as the time to the first event (TY), favorable results for Metoprolol over placebo, and relative risk with a 95% confidence interval. There is also mention of non-US data, New York Heart Association, ejection fraction, and heart attacks.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.